Income Statement (TTM)
Prostatype Genomics AB (publ) Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 4 | 4 | 3 | 2 | 1 | 1 |
| Change (%) | 1.72 | -1.73 | -4.30 | -12.78 | -21.48 | -27.42 | -22.14 | -38.66 | 19.14 | 81.30 | 82.95 | 38.12 | 8.93 | 1.36 | -26.69 | -36.44 | -31.36 | -45.69 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 8 | 9 | 9 | 9 | 8 | 9 | 11 | 12 | 13 | 15 | 17 | 19 | 20 | 16 | 11 | 12 | 22 | 22 | 22 |
| Change (%) | 22.52 | -2.04 | -1.76 | -5.36 | 1.75 | 33.04 | 6.65 | 10.03 | 10.33 | 15.98 | 10.43 | 4.05 | -17.21 | -35.05 | 8.70 | 92.86 | -1.25 | -1.27 | |
| % of Revenue | 252.99 | 304.72 | 303.75 | 311.81 | 338.34 | 438.44 | 803.69 | 1,100.95 | 1,974.96 | 1,828.96 | 1,169.96 | 706.21 | 531.97 | 404.34 | 259.09 | 384.14 | 1,165.54 | 1,676.79 | 3,048.25 |
| Gross Operating Profit | -5 | -6 | -6 | -6 | -6 | -7 | -10 | -11 | -13 | -14 | -16 | -16 | -16 | -12 | -7 | -9 | -20 | -21 | -21 |
| Change (%) | 36.11 | -2.19 | -0.51 | -1.85 | 11.49 | 50.91 | 10.75 | 14.90 | 9.86 | 12.20 | 3.65 | -1.58 | -23.26 | -47.02 | 30.94 | 138.36 | 1.57 | 1.55 | |
| % of Revenue | -152.99 | -204.72 | -203.75 | -211.81 | -238.34 | -338.44 | -703.69 | -1,000.95 | -1,874.96 | -1,728.96 | -1,069.96 | -606.21 | -431.97 | -304.34 | -159.09 | -284.14 | -1,065.54 | -1,576.79 | -2,948.25 |
| SG&A | 6 | 7 | 7 | 7 | 8 | 8 | 9 | 10 | 10 | 12 | 14 | 16 | 18 | 24 | 28 | 27 | 16 | 16 | 16 |
| Change (%) | 10.91 | -1.29 | 4.06 | 17.77 | 6.39 | 7.68 | 11.69 | 1.73 | 11.04 | 24.74 | 14.17 | 10.20 | 33.57 | 17.45 | -3.30 | -42.80 | 0.12 | 0.12 | |
| % of Revenue | 197.75 | 215.63 | 216.59 | 235.51 | 318.00 | 430.89 | 639.24 | 917.02 | 1,520.94 | 1,417.55 | 975.33 | 608.63 | 485.57 | 595.42 | 689.92 | 910.06 | 819.03 | 1,194.64 | 2,202.24 |
| R&D | 2 | 1 | 0 | 1 | 1 | 2 | 2 | 3 | 4 | 3 | 4 | 3 | 3 | 3 | 1 | 1 | 2 | 2 | 2 |
| Change (%) | -31.46 | -53.12 | 54.50 | 94.83 | 32.63 | 25.11 | 37.31 | 3.47 | -4.09 | 23.58 | -19.04 | -4.20 | -16.44 | -56.43 | 2.43 | 83.87 | 0.00 | 0.00 | |
| % of Revenue | 51.15 | 34.47 | 16.44 | 26.55 | 59.30 | 100.16 | 172.65 | 304.49 | 513.62 | 413.47 | 281.84 | 124.73 | 86.51 | 66.36 | 28.52 | 39.85 | 115.28 | 167.95 | 309.23 |
| OpEx | 15 | 17 | 16 | 17 | 18 | 20 | 24 | 27 | 29 | 32 | 38 | 41 | 43 | 45 | 42 | 43 | 43 | 43 | 42 |
| Change (%) | 12.12 | -4.89 | 2.23 | 8.56 | 8.88 | 22.80 | 13.48 | 7.20 | 8.13 | 18.92 | 7.81 | 5.55 | 5.21 | -6.56 | 0.62 | 0.62 | -0.63 | -0.63 | |
| % of Revenue | 507.31 | 559.22 | 541.19 | 578.12 | 719.54 | 997.78 | 1,688.13 | 2,460.61 | 4,300.44 | 3,903.11 | 2,560.09 | 1,508.58 | 1,152.76 | 1,113.43 | 1,026.46 | 1,408.80 | 2,230.03 | 3,228.48 | 5,906.85 |
| Operating Income | -12 | -14 | -13 | -14 | -16 | -18 | -23 | -26 | -29 | -31 | -36 | -38 | -39 | -41 | -38 | -39 | -41 | -41 | -42 |
| Change (%) | 14.68 | -5.58 | 3.71 | 13.02 | 13.78 | 28.39 | 15.73 | 9.14 | 7.87 | 17.28 | 4.75 | 3.23 | 4.86 | -7.34 | 3.57 | 3.45 | 0.81 | 0.81 | |
| % of Revenue | -407.31 | -459.22 | -441.19 | -478.12 | -619.54 | -897.78 | -1,588.13 | -2,360.61 | -4,200.44 | -3,803.11 | -2,460.09 | -1,408.58 | -1,052.76 | -1,013.43 | -926.46 | -1,308.80 | -2,130.03 | -3,128.48 | -5,806.85 |
| Interest Expense | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 | -2 | -2 | -2 | -2 | -2 | -1 | -1 |
| Change (%) | 0.23 | -71.18 | -28.73 | -72.43 | -11.89 | 2.47 | 437.46 | 0.39 | -0.35 | 3.11 | 99.45 | 89.30 | 25.71 | 19.94 | -13.89 | -16.13 | -17.89 | -21.79 | |
| % of Revenue | -47.74 | -47.04 | -13.79 | -10.27 | -3.25 | -3.64 | -5.14 | -35.52 | -58.13 | -48.62 | -27.65 | -30.14 | -41.31 | -47.67 | -56.41 | -66.26 | -87.43 | -104.60 | -150.63 |
| Net Income | -14 | -15 | -14 | -14 | -16 | -18 | -23 | -27 | -29 | -31 | -37 | -39 | -41 | -43 | -41 | -41 | -41 | -43 | -45 |
| Change (%) | 13.16 | -11.68 | 2.73 | 11.22 | 13.65 | 28.29 | 17.09 | 9.02 | 7.75 | 17.10 | 6.69 | 5.82 | 4.88 | -6.71 | 0.63 | 0.62 | 5.18 | 4.93 | |
| % of Revenue | -455.05 | -506.26 | -454.99 | -488.40 | -622.79 | -901.42 | -1,593.28 | -2,396.12 | -4,258.71 | -3,851.62 | -2,487.74 | -1,450.75 | -1,111.45 | -1,070.16 | -984.99 | -1,352.00 | -2,140.30 | -3,279.79 | -6,336.50 |
Source: Capital IQ
